OGN Form 3: Officer holds 14,790.703 shares and RSU awards at Organon

Q: What did Organon (OGN) disclose in this Form 3?

An officer reported beneficial ownership of 14,790.703 shares of common stock (direct) and multiple RSU awards tied to Organon common stock.

Q: How many Organon (OGN) common shares are directly owned?

The filing reports 14,790.703 shares of common stock held directly.

Q: What RSU awards are included and when do they vest?

RSUs for 6,378 (final vesting 03/31/2026), 7,252 (11/07/2026), 15,958 (03/29/2027), and 30,221 (03/31/2028) are listed; each vests in one‑third annual installments.

Q: What is the reporting person’s relationship to Organon (OGN)?

The reporting person is an Officer, titled Interim Head of Mfg & Supply.

Organon & Co. (OGN) filed a Form 3 for an officer serving as Interim Head of Mfg & Supply.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Organon & Co. (OGN) filed a Form 3 for an officer serving as Interim Head of Mfg & Supply. The report shows 14,790.703 shares of common stock held directly.

It also lists restricted stock units (each RSU equals one share) covering common stock: 6,378 (exercisable 03/31/2025; final vesting 03/31/2026), 7,252 (11/07/2025; 11/07/2026), 15,958 (03/29/2026; 03/29/2027), and 30,221 (03/31/2026; 03/31/2028). The event date is 10/27/2025.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Drinane Juliana Papa

Role Interim Head of Mfg & Supply

Type	Security	Shares	Price	Value
holding	Restricted Stock Units	--	--	--
holding	Restricted Stock Units	--	--	--
holding	Restricted Stock Units	--	--	--
holding	Restricted Stock Units	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 59,809 contracts (Direct); Common Stock — 14,790.703 shares (Direct)

Footnotes (5)

F1. 19,132 restricted stock units ("RSUs") were granted on March 31, 2023, and one-third vest each year with the final vesting date being March 31, 2026.
F2. Each RSU represents a contingent right to receive one share of common stock of Organon & Co.
F3. 10,876 RSUs were granted on November 7, 2023, and one-third vest each year with the final vesting date being November 7, 2026.
F4. 23,936 RSUs were granted on March 29, 2024, and one-third vest each year with the final vesting date being March 29, 2027.
F5. 30,221 RSUs were granted on March 31, 2025, and one-third vest each year with the final vesting date being March 31, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Organon (OGN) disclose in this Form 3?

An officer reported beneficial ownership of 14,790.703 shares of common stock (direct) and multiple RSU awards tied to Organon common stock.

How many Organon (OGN) common shares are directly owned?

The filing reports 14,790.703 shares of common stock held directly.

What RSU awards are included and when do they vest?

RSUs for 6,378 (final vesting 03/31/2026), 7,252 (11/07/2026), 15,958 (03/29/2027), and 30,221 (03/31/2028) are listed; each vests in one‑third annual installments.

What does each RSU represent for OGN?

Each RSU represents a contingent right to receive one share of Organon common stock.

What is the reporting person’s relationship to Organon (OGN)?

The reporting person is an Officer, titled Interim Head of Mfg & Supply.

What is the event date for this beneficial ownership report?

The event date is 10/27/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/12/2025 - 05:47 PM EST

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Drinane Juliana Papa

(Last)

(First)

(Middle)

C/O ORGANON &CO.

30 HUDSON STREET, FLOOR 33

(Street)

JERSEY CITY

07302

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/27/2025

3. Issuer Name and Ticker or Trading Symbol
Organon & Co. [ OGN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Interim Head of Mfg & Supply

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14,790.703	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	03/31/2025⁽¹⁾	03/31/2026	Common Stock	6,378	⁽²⁾	D
Restricted Stock Units	11/07/2025⁽³⁾	11/07/2026	Common Stock	7,252	⁽²⁾	D
Restricted Stock Units	03/29/2026⁽⁴⁾	03/29/2027	Common Stock	15,958	⁽²⁾	D
Restricted Stock Units	03/31/2026⁽⁵⁾	03/31/2028	Common Stock	30,221	⁽²⁾	D

Explanation of Responses:

1. 19,132 restricted stock units ("RSUs") were granted on March 31, 2023, and one-third vest each year with the final vesting date being March 31, 2026.

2. Each RSU represents a contingent right to receive one share of common stock of Organon & Co.

3. 10,876 RSUs were granted on November 7, 2023, and one-third vest each year with the final vesting date being November 7, 2026.

4. 23,936 RSUs were granted on March 29, 2024, and one-third vest each year with the final vesting date being March 29, 2027.

5. 30,221 RSUs were granted on March 31, 2025, and one-third vest each year with the final vesting date being March 31, 2028.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Tarnetta V. Jones, as Attorney-in-Fact for Juliana Drinane	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR